• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

序列分析来自印度奥里萨邦疟疾流行地区的青蒿素耐药性分离株中的 -Propeller 基因:分子监测研究。

Sequence Analysis of the -Propeller Gene in Artemisinin Challenging Isolates from Malaria Endemic Areas of Odisha, India: A Molecular Surveillance Study.

机构信息

Division of Molecular Epidemiology and Public Health, ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.

Division of Vector Borne Diseases, ICMR-National Institute of Research in Tribal Health, Jabalpur, India.

出版信息

Biomed Res Int. 2020 Mar 15;2020:8475246. doi: 10.1155/2020/8475246. eCollection 2020.

DOI:10.1155/2020/8475246
PMID:32258150
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7102476/
Abstract

Estimation of the spread and advancement of artemisinin-resistant parasites can be done by probing polymorphisms in the kelch () domain (a validated molecular marker). This study aimed to provide baseline information for future artemisinin surveillance by analyzing the -propeller domain in field isolates collected from 24 study areas in 14 malaria hot spots of Odisha (previously Orissa) during July 2018-January 2019. A total of 178 mono infections were assessed. An 849-base pair fragment encoding the propeller was amplified by nested polymerase chain reaction and sequenced in both directions (PCR). After DNA alignment with the 3D7 reference sequence, all samples were found to be wild type. It can be anticipated that malaria public health is not under direct threat in Odisha relating to ART resistance.

摘要

可以通过探测kelch()结构域(一个经过验证的分子标记)中的多态性来估计青蒿素耐药寄生虫的传播和进展。本研究旨在通过分析 2018 年 7 月至 2019 年 1 月在奥里萨邦(以前的奥里萨邦)14 个疟疾热点的 24 个研究地区采集的现场分离株中的-推进器结构域,为未来的青蒿素监测提供基线信息。总共评估了 178 例单感染。通过巢式聚合酶链反应(PCR)扩增编码 推进器的 849 个碱基对片段,并进行双向测序。与 3D7 参考序列进行 DNA 比对后,所有样本均为野生型。可以预期,奥里萨邦的疟疾公共卫生不会直接受到与 ART 耐药性相关的威胁。

相似文献

1
Sequence Analysis of the -Propeller Gene in Artemisinin Challenging Isolates from Malaria Endemic Areas of Odisha, India: A Molecular Surveillance Study.序列分析来自印度奥里萨邦疟疾流行地区的青蒿素耐药性分离株中的 -Propeller 基因:分子监测研究。
Biomed Res Int. 2020 Mar 15;2020:8475246. doi: 10.1155/2020/8475246. eCollection 2020.
2
Absence of K13 Propeller Domain Polymorphisms among Field Isolates Collected from the Brazilian Amazon Basin between 1984 and 2011.1984 年至 2011 年期间在巴西亚马逊河流域采集的野外分离株中不存在 K13 桨叶结构域多态性。
Am J Trop Med Hyg. 2018 Dec;99(6):1504-1507. doi: 10.4269/ajtmh.18-0554. Epub 2018 Sep 27.
3
Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012-2013.2012 - 2013年从塞内加尔达喀尔分离出的恶性疟原虫中k13基因的有限多态性
Malar J. 2014 Dec 4;13:472. doi: 10.1186/1475-2875-13-472.
4
No polymorphisms in K13-propeller gene associated with artemisinin resistance in Plasmodium falciparum isolated from Brazzaville, Republic of Congo.在刚果共和国布拉柴维尔分离的恶性疟原虫中,K13 推进器基因没有与青蒿素耐药性相关的多态性。
BMC Infect Dis. 2018 Oct 29;18(1):538. doi: 10.1186/s12879-018-3453-6.
5
Molecular surveillance of Kelch-13 gene in Plasmodium falciparum field isolates from Mayurbhanj District, Odisha, India, and in silico artemisinin-Kelch-13 protein interaction study.印度奥里萨邦玛雅布汉杰区疟原虫野外分离株 Kelch-13 基因的分子监测及青蒿素-Kelch-13 蛋白相互作用的计算机模拟研究。
Parasitol Res. 2023 Mar;122(3):717-727. doi: 10.1007/s00436-023-07784-9. Epub 2023 Feb 2.
6
Polymorphisms in K13 and falcipain-2 associated with artemisinin resistance are not prevalent in Plasmodium falciparum isolated from Ugandan children.与青蒿素耐药性相关的K13和恶性疟原虫蛋白酶-2多态性在从乌干达儿童中分离出的恶性疟原虫中并不普遍。
PLoS One. 2014 Aug 21;9(8):e105690. doi: 10.1371/journal.pone.0105690. eCollection 2014.
7
Genetic association between the Pfk13 gene mutation and artemisinin resistance phenotype in Plasmodium falciparum isolates from Yunnan Province, China.在中国云南省的疟原虫分离株中 Pfk13 基因突变与青蒿素耐药表型的遗传关联。
Malar J. 2018 Dec 18;17(1):478. doi: 10.1186/s12936-018-2619-4.
8
Molecular surveillance of drug resistance: Plasmodium falciparum artemisinin resistance single nucleotide polymorphisms in Kelch protein propeller (K13) domain from Southern Pakistan.分子耐药监测:来自巴基斯坦南部的疟原虫青蒿素耐药单核苷酸多态性在 Kelch 蛋白螺旋桨(K13)结构域。
Malar J. 2021 Apr 7;20(1):176. doi: 10.1186/s12936-021-03715-0.
9
Limited artemisinin resistance-associated polymorphisms in Plasmodium falciparum K13-propeller and PfATPase6 gene isolated from Bioko Island, Equatorial Guinea.从赤道几内亚比奥科岛分离出的恶性疟原虫K13螺旋桨蛋白和PfATPase6基因中与青蒿素耐药性相关的多态性有限。
Int J Parasitol Drugs Drug Resist. 2016 Jan 12;6(1):54-59. doi: 10.1016/j.ijpddr.2015.11.002. eCollection 2016 Apr.
10
Polymorphisms of the artemisinin resistant marker (K13) in Plasmodium falciparum parasite populations of Grande Comore Island 10 years after artemisinin combination therapy.青蒿素联合疗法实施10年后,大科摩罗岛恶性疟原虫种群中青蒿素抗性标志物(K13)的多态性
Parasit Vectors. 2015 Dec 15;8:634. doi: 10.1186/s13071-015-1253-z.

引用本文的文献

1
Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa.非洲青蒿素部分耐药疟原虫的出现、传播动态和机制。
Nat Rev Microbiol. 2024 Jun;22(6):373-384. doi: 10.1038/s41579-024-01008-2. Epub 2024 Feb 6.
2
Plasmodium falciparum kelch13 polymorphisms identified after treatment failure with artemisinin-based combination therapy in Niger.尼日尔青蒿素为基础的联合疗法治疗失败后鉴定出恶性疟原虫 Kelch13 多态性。
Malar J. 2023 May 1;22(1):142. doi: 10.1186/s12936-023-04571-w.
3
Prevalence of Mutations in the , and Genes of Malarial Parasites Isolated from Symptomatic Patients in Dogondoutchi, Niger.从尼日尔多贡杜奇有症状患者中分离出的疟原虫的、和基因的突变流行率。
Trop Med Infect Dis. 2022 Jul 29;7(8):155. doi: 10.3390/tropicalmed7080155.
4
Artemisinin combination therapy fails even in the absence of Plasmodium falciparum kelch13 gene polymorphism in Central India.在印度中部,即使不存在恶性疟原虫 Kelch13 基因多态性,青蒿素联合疗法也会失败。
Sci Rep. 2021 May 11;11(1):9946. doi: 10.1038/s41598-021-89295-0.
5
The effectiveness of malaria camps as part of the Durgama Anchalare Malaria Nirakaran (DAMaN) program in Odisha, India: study protocol for a cluster-assigned quasi-experimental study.疟疾营地作为印度奥里萨邦 Durgama Anchalare Malaria Nirakaran(DAMaN)计划的一部分的效果:一项基于群组分配的准实验研究的研究方案。
Glob Health Action. 2021 Jan 1;14(1):1886458. doi: 10.1080/16549716.2021.1886458.

本文引用的文献

1
Artemisinin resistance-associated markers in Plasmodium falciparum parasites from the China-Myanmar border: predicted structural stability of K13 propeller variants detected in a low-prevalence area.来自中缅边境地区恶性疟原虫中的青蒿素耐药相关标记物:在低流行地区检测到的 K13 螺旋桨变异体的预测结构稳定性。
PLoS One. 2019 Mar 18;14(3):e0213686. doi: 10.1371/journal.pone.0213686. eCollection 2019.
2
K13-propeller gene polymorphisms in Plasmodium falciparum parasite population in malaria affected countries: a systematic review of prevalence and risk factors.疟疾病原体人群中 K13-螺旋桨基因多态性:流行情况和危险因素的系统评价
Malar J. 2019 Mar 7;18(1):60. doi: 10.1186/s12936-019-2701-6.
3
Novel pfkelch13 Gene Polymorphism Associates With Artemisinin Resistance in Eastern India.新型 pfkelch13 基因突变与印度东部的青蒿素耐药性相关。
Clin Infect Dis. 2019 Sep 13;69(7):1144-1152. doi: 10.1093/cid/ciy1038.
4
Evidence of Artemisinin-Resistant Plasmodium falciparum Malaria in Eastern India.印度东部出现对青蒿素耐药的恶性疟原虫疟疾的证据。
N Engl J Med. 2018 Nov 15;379(20):1962-1964. doi: 10.1056/NEJMc1713777.
5
Status of Artemisinin Resistance in Malaria Parasite from Molecular Analyses of the Gene in Southwestern Nigeria.来自尼日利亚西南部疟原虫基因分子分析的青蒿素耐药现状。
Biomed Res Int. 2018 Oct 3;2018:2305062. doi: 10.1155/2018/2305062. eCollection 2018.
6
Absence of K13 Polymorphism in Plasmodium falciparum from Brazilian Areas Where the Parasite Is Endemic.巴西流行地区恶性疟原虫无 K13 多态性。
Antimicrob Agents Chemother. 2018 Sep 24;62(10). doi: 10.1128/AAC.00354-18. Print 2018 Oct.
7
Drug resistance in Plasmodium.疟原虫的耐药性。
Nat Rev Microbiol. 2018 Mar;16(3):156-170. doi: 10.1038/nrmicro.2017.161. Epub 2018 Jan 22.
8
The threat of antimalarial drug resistance.抗疟药物耐药性的威胁。
Trop Dis Travel Med Vaccines. 2016 Jul 7;2:10. doi: 10.1186/s40794-016-0027-8. eCollection 2016.
9
Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic.抗疟药物耐药性:将恶性疟原虫生物学与临床联系起来
Nat Med. 2017 Aug 4;23(8):917-928. doi: 10.1038/nm.4381.
10
Combating multidrug-resistant Plasmodium falciparum malaria.对抗耐多药恶性疟原虫疟疾
FEBS J. 2017 Aug;284(16):2569-2578. doi: 10.1111/febs.14127. Epub 2017 Jun 30.